• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Pneumococcal Vaccine Polyvalent Market Research Report 2024(Status and Outlook)

Global Pneumococcal Vaccine Polyvalent Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 07 August 2024
  • Pages :100
  • Formats:
  • Report Code:24MRES-7981977
Click for best price

Best Price: $2600

The global Pneumococcal Vaccine Polyvalent market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Report Overview

Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
This report provides a deep insight into the global Pneumococcal Vaccine Polyvalent market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Vaccine Polyvalent Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Vaccine Polyvalent market in any manner.
Global Pneumococcal Vaccine Polyvalent Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company

  • Merck & Co.
  • Pfizer

Market Segmentation (by Type)
  • Prevnar 13
  • Pneumovax23

Market Segmentation (by Application)
  • 18 Years and Younger
  • 19 To 64 Years Old
  • 65 Years and Older

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Pneumococcal Vaccine Polyvalent Market

Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccine Polyvalent Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
 

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pneumococcal Vaccine Polyvalent
1.2 Key Market Segments
1.2.1 Pneumococcal Vaccine Polyvalent Segment by Type
1.2.2 Pneumococcal Vaccine Polyvalent Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pneumococcal Vaccine Polyvalent Market Overview
2.1 Global Market Overview
2.1.1 Global Pneumococcal Vaccine Polyvalent Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pneumococcal Vaccine Polyvalent Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pneumococcal Vaccine Polyvalent Market Competitive Landscape
3.1 Global Pneumococcal Vaccine Polyvalent Sales by Manufacturers (2019-2024)
3.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturers (2019-2024)
3.3 Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pneumococcal Vaccine Polyvalent Sales Sites, Area Served, Product Type
3.6 Pneumococcal Vaccine Polyvalent Market Competitive Situation and Trends
3.6.1 Pneumococcal Vaccine Polyvalent Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pneumococcal Vaccine Polyvalent Industry Chain Analysis
4.1 Pneumococcal Vaccine Polyvalent Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pneumococcal Vaccine Polyvalent Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pneumococcal Vaccine Polyvalent Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2019-2024)
6.3 Global Pneumococcal Vaccine Polyvalent Market Size Market Share by Type (2019-2024)
6.4 Global Pneumococcal Vaccine Polyvalent Price by Type (2019-2024)
7 Pneumococcal Vaccine Polyvalent Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccine Polyvalent Market Sales by Application (2019-2024)
7.3 Global Pneumococcal Vaccine Polyvalent Market Size (M USD) by Application (2019-2024)
7.4 Global Pneumococcal Vaccine Polyvalent Sales Growth Rate by Application (2019-2024)
8 Pneumococcal Vaccine Polyvalent Market Segmentation by Region
8.1 Global Pneumococcal Vaccine Polyvalent Sales by Region
8.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Region
8.1.2 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumococcal Vaccine Polyvalent Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumococcal Vaccine Polyvalent Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumococcal Vaccine Polyvalent Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck and Co.
9.1.1 Merck and Co. Pneumococcal Vaccine Polyvalent Basic Information
9.1.2 Merck and Co. Pneumococcal Vaccine Polyvalent Product Overview
9.1.3 Merck and Co. Pneumococcal Vaccine Polyvalent Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. Pneumococcal Vaccine Polyvalent SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 Pfizer
9.2.1 Pfizer Pneumococcal Vaccine Polyvalent Basic Information
9.2.2 Pfizer Pneumococcal Vaccine Polyvalent Product Overview
9.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Pneumococcal Vaccine Polyvalent SWOT Analysis
9.2.6 Pfizer Recent Developments
10 Pneumococcal Vaccine Polyvalent Market Forecast by Region
10.1 Global Pneumococcal Vaccine Polyvalent Market Size Forecast
10.2 Global Pneumococcal Vaccine Polyvalent Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumococcal Vaccine Polyvalent Market Size Forecast by Country
10.2.3 Asia Pacific Pneumococcal Vaccine Polyvalent Market Size Forecast by Region
10.2.4 South America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumococcal Vaccine Polyvalent by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pneumococcal Vaccine Polyvalent Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pneumococcal Vaccine Polyvalent by Type (2025-2030)
11.1.2 Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pneumococcal Vaccine Polyvalent by Type (2025-2030)
11.2 Global Pneumococcal Vaccine Polyvalent Market Forecast by Application (2025-2030)
11.2.1 Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) Forecast by Application
11.2.2 Global Pneumococcal Vaccine Polyvalent Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Vaccine Polyvalent Market Size Comparison by Region (M USD)
Table 5. Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Vaccine Polyvalent Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2022)
Table 10. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pneumococcal Vaccine Polyvalent Sales Sites and Area Served
Table 12. Manufacturers Pneumococcal Vaccine Polyvalent Product Type
Table 13. Global Pneumococcal Vaccine Polyvalent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumococcal Vaccine Polyvalent
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccine Polyvalent Market Challenges
Table 22. Global Pneumococcal Vaccine Polyvalent Sales by Type (Kilotons)
Table 23. Global Pneumococcal Vaccine Polyvalent Market Size by Type (M USD)
Table 24. Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2019-2024)
Table 26. Global Pneumococcal Vaccine Polyvalent Market Size (M USD) by Type (2019-2024)
Table 27. Global Pneumococcal Vaccine Polyvalent Market Size Share by Type (2019-2024)
Table 28. Global Pneumococcal Vaccine Polyvalent Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) by Application
Table 30. Global Pneumococcal Vaccine Polyvalent Market Size by Application
Table 31. Global Pneumococcal Vaccine Polyvalent Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2019-2024)
Table 33. Global Pneumococcal Vaccine Polyvalent Sales by Application (2019-2024) & (M USD)
Table 34. Global Pneumococcal Vaccine Polyvalent Market Share by Application (2019-2024)
Table 35. Global Pneumococcal Vaccine Polyvalent Sales Growth Rate by Application (2019-2024)
Table 36. Global Pneumococcal Vaccine Polyvalent Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2019-2024)
Table 38. North America Pneumococcal Vaccine Polyvalent Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pneumococcal Vaccine Polyvalent Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck and Co. Pneumococcal Vaccine Polyvalent Basic Information
Table 44. Merck and Co. Pneumococcal Vaccine Polyvalent Product Overview
Table 45. Merck and Co. Pneumococcal Vaccine Polyvalent Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. Pneumococcal Vaccine Polyvalent SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. Pfizer Pneumococcal Vaccine Polyvalent Basic Information
Table 50. Pfizer Pneumococcal Vaccine Polyvalent Product Overview
Table 51. Pfizer Pneumococcal Vaccine Polyvalent Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Pneumococcal Vaccine Polyvalent SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Pneumococcal Vaccine Polyvalent Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Pneumococcal Vaccine Polyvalent Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Pneumococcal Vaccine Polyvalent Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccine Polyvalent
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccine Polyvalent Market Size (M USD), 2019-2030
Figure 5. Global Pneumococcal Vaccine Polyvalent Market Size (M USD) (2019-2030)
Figure 6. Global Pneumococcal Vaccine Polyvalent Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccine Polyvalent Market Size by Country (M USD)
Figure 11. Pneumococcal Vaccine Polyvalent Sales Share by Manufacturers in 2023
Figure 12. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers in 2023
Figure 13. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccine Polyvalent Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumococcal Vaccine Polyvalent Market Share by Type
Figure 18. Sales Market Share of Pneumococcal Vaccine Polyvalent by Type (2019-2024)
Figure 19. Sales Market Share of Pneumococcal Vaccine Polyvalent by Type in 2023
Figure 20. Market Size Share of Pneumococcal Vaccine Polyvalent by Type (2019-2024)
Figure 21. Market Size Market Share of Pneumococcal Vaccine Polyvalent by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumococcal Vaccine Polyvalent Market Share by Application
Figure 24. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2019-2024)
Figure 25. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2023
Figure 26. Global Pneumococcal Vaccine Polyvalent Market Share by Application (2019-2024)
Figure 27. Global Pneumococcal Vaccine Polyvalent Market Share by Application in 2023
Figure 28. Global Pneumococcal Vaccine Polyvalent Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2019-2024)
Figure 30. North America Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2023
Figure 32. U.S. Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pneumococcal Vaccine Polyvalent Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pneumococcal Vaccine Polyvalent Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2023
Figure 37. Germany Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pneumococcal Vaccine Polyvalent Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region in 2023
Figure 44. China Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pneumococcal Vaccine Polyvalent Sales and Growth Rate (Kilotons)
Figure 50. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2023
Figure 51. Brazil Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pneumococcal Vaccine Polyvalent Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pneumococcal Vaccine Polyvalent Market Share Forecast by Type (2025-2030)
Figure 65. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Application (2025-2030)
Figure 66. Global Pneumococcal Vaccine Polyvalent Market Share Forecast by Application (2025-2030)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount